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ABSTRACT
Neurobrucellosis (NB) is one of the most serious complications of brucellosis, as a chronic
granulomatous zoonotic infection. It may be acute or chronic with central and / or peripheral
nervous system involvement. Pediatric NB is usually acute central form. We report a nine years
old girl as a case of NB with sudden onset of hemi paresis, aphasia and bilateral sensory neural
hearing loss.
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INTRODUCTION
Brucellosis is a chronic granulomatous
zoonotic infection that may transmit to human.
It is still a public health problem in Iran with
an incidence rate of about 34-105/ one hun-
dred thousand population in different
provinces.1,2 Neurobrucellosis (NB)  is an
uncommon complication of brucellosis with
pediatric risk of about 0.8%.3
Paediatric neurobrucellosis usually involves
the central nervous system and it is usually of
acute presentation, with duration of symptoms
between 0.5-8 weeks.3
We report a nine years old girl as a case of
NB with bilateral sensory neural hearing loss,
sudden onset of hemi paresis and aphasia.
CASE REPORT
A nine years old girl with complaint of
malaise, anorexia, nausea, and vomiting for
two weeks, sudden onset of left hemi paresis
and aphasia was admitted in pediatric neu-
rology ward of our Hospital. Physical exami-
nation at first, revealed bilateral 8th cranial
nerve involvement decreased muscle force
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(4/5) and increased deep tendon reflex (DTR)
of left lower extremity. Early laboratory tests
including CBC, ESR, electrolytes and LFT were
at normal limits, but CSF analysis had some
abnormalities (Table-I).
Brain CT revealed mild communicating
hydrocephaly and brain MRI showed patchy
hyperintense areas in pons, periventricular
white matter, parietal, temporal, and frontal
lobes in T2W images (Fig-1,2). At first with
impression of Acute Disseminated Encephalo-
myelitis (ADEM), she was treated with
methylprednisolon without any improvement.
She developed fever and nuchal rigidity after
third day of treatment and was referred to
infectious ward.
According to clinical and lab findings, tuber-
culous meningitis was considered and anti TB
drugs (PZA, ETB, INH and RIF) and
dexametasone was prescribed.
Four days after anti-TB therapy, we received
the following results: negative TB- PCR in CSF,
serum wright titer of 1/ 2560 with CSF wright
titer of 1/ 20, therefore we discontinued anti-
TB drugs except rifampin and added
cotrimoxazole and doxycycline to previous
drugs with diagnosis of NB. Dexamethasone
was discontinued after one month but antibi-
otics were continued up to six months accord-
ing   to clinical state and CSF analysis result.
 Lumbar puncture was repeated on third day,
7th day, second month and 6th month later
when treatment was discontinued. Hemipare-
sis and aphasia recovered after one month but
sensoryneural hearing loss did not improve
despite of therapy.
DISCUSSION
Brucellosis caused by intracellular gram-
negative bacteria of the genus brucella, is
Table-I: Serial CSF analysis of the reported case with neurobrucellosis
First Second3th day Third 7th day 4th2nd month 5th6 th onth
WBC/cc 2 50 70 30 0-1
Poly 20% 95%
Lymph 100% 80% 5% 100%
RBC/cc 2 0 180 10 0
Glucose mg/dl 20 10 70 18 27
Simultaneous 150 120 127 122 110
  Blood glucose mg/dl
Protein mg/dl 370 480 240 184 172
Gram stain Neg Neg Neg Neg Neg
Culture Neg Neg Neg Neg Neg
Fig-2: Brain MRI showed patchy hyperintense areas
Fig-1: Brain CT revealed mild communicating
hydrocephaly
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transmitted to human through consumption
of meat, raw milk or infected milk products,
contact with infected animals or through
the respiratory tract, abraded skin or
conjunctiva.4,5
This world wide disease with estimated
incidence of half a million annually, is endemic
in middle east area, western Asia, Africa and
Latin America.6-8 It is still a major   health
problem in Iran with incidence of about 34-
105/ 100000.1,2
NB is an uncommon complication of this
disease with incidence of 0.8% and7% in chil-
dren and adults’ respectively.3 It may be acute
or chronic with central and / or peripheral ner-
vous system involvement. Pediatric NB is
usually acute central form and peripheral
neuropathy has not yet been reported in
childhood NB. 3
NB may present with brain abscess, sub-
arachnoid hemorrhage, cranial nerve involve-
ment and other sensory or motor abnormali-
ties.3,7 The patient may be manifested with
meningeal irritation, deep tendon hyperreflexia
or areflexia with or without constitutional
symptoms.3 Also brucella meningitis has been
described without fever, neck stiffness or ab-
normal CSF findings.3 As regards our patient’s
clinical, laboratory and imaging findings,
ADEM, TB meningitis and NB were suggested.
History of recent infectious illness or immuni-
zation, increased CSF myelin protein,
increased CSF/serum IgG ratio and thromb-
ocytosis which can be found in ADEM helps
to differentiate ADEM from NB.9 In addition,
Intraparenchymal subcortical enhancement
that may be found in ADEM   has not yet been
described in NB.10
History of contact with index case, positive
PPD, abnormal CXR and positive CSF PCR or
Culture can help to differentiate TB meningi-
tis from NB. Basilar enhancement and commu-
nicating hydrocephalus are most prevalent
imaging findings in TB meningitis and could
also be found in NB.11
CNS abnormalities in NB are of three types:
white matter involvement, inflammatory
changes and vascular insult.10 White matter
involvement may mimic other inflammatory or
infectious diseases such as ADEM, Multiple
Sclerosis (MS) and lyme disease, but involve-
ment of corpus callosum in MS and
imtraparenchymal subcortical enhancement in
MS, ADEM and lyme disease have not yet been
described in NB.10
The criteria necessary for definite NB diag-
nosis include:
* Increased protein in CSF and lymphocyte
pleocytosis
* Positive CSF culture for brucella or positive
brucella IgG agglutination titer in the blood
and CSF.
* Response to specific chemotherapy with a
significant drop in the CSF lymphocyte
count and protein concentration.
* Dysfunction not explained by other
neurologic diseases,5 so our patient had all
definite NB criteria.
Increased WBC count with PMN predomi-
nance of CSF after four days anti-TB therapy
in our patient (third LP) can be explained with
Jarish – herxheimer like reaction and release
of excess brucella endotoxin which can aug-
ment the immune response.3 Habeeb and
coworkers reported an eight year old boy with
brucella meningitis who demonstrated a arisch-
Herxheimer-like reaction, presented with clini-
cal deterioration following the commencement
of antibrucella treatment, associated with in-
creased pleocytosis and shift from lymphocytic
to polymorphic predominance. However this
picture may be modified if steroids have been
used.3
CSF glucose is not a reliable index for evalu-
ation of response to therapy in NB as our pa-
tient had hypoglycorrhatia despite of comple-
tion of treatment.12 Hearing loss is among the
rare complications generally occurring with
neurobrucellosis, mostly of sensorineural
type.13 It appears that hearing loss in brucello-
sis is possibly due to involvement of the cen-
tral auditory pathways although a mixed-type
hearing loss after Brucella infection has been
reported.14 Several studies have suggested that
cerebral inflammation caused by infections, or
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avascular neural tissue resulting from reflex
spasm caused by endotoxins, can be the cause
of hearing loss in brucellosis.5 Treatment should
be initiated as soon as possible to prevent per-
manent hearing loss and later relapses and
long-term combination therapy is required in
such cases. Mc Lean et al reported that four of
18 cases treated for neurobrucellosis suffered
from permanent hearing loss.15 Unfortunately
sensoryneural hearing loss did not improve in
our patient despite of therapy.
Since NB is a complication of systemic
brucellar infection, patients should be given a
combination of drugs that are both able to
cover current treatment of brucellosis and
achieve high levels in CSF. Triple regimens
comprising doxycycline, rifampicin and
cotrimoxazole are recommended because they
have good intracellular and CNS penetration
and may act in a synergistic fashion. The
actual duration of therapy is predicated by the
clinical and CSF response. Some authors also
recommend concomitant steroid administra-
tion.16 Steroids have been used in
neurobrucellosis when deterioration occurs
after initiating antibrucella treatment as well
as for optic neuropathy, papilloedema, cranial
nerve involvement and arachnoiditis.3
CONCLUSIONS
Persistent aseptic meningitis with unusual
presentations such as neurologic deficits should
be an alarm signal to physicians to evaluate
the patient for TB and brucellosis in endemic
areas. In suspected cases, treatment should be
started immediately before receiving laboratory
results. In addition, every patient with acute
paresis or chronic sensorineural hearing loss
should be evaluated for infectious causes such
as NB if other possible causes are ruled out.
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